balleroni, this just keeps getting better and bett
Post# of 36537
Quote:
The company’s share price has soared more than six times in value since August on its announcement to enter into distribution and licensing agreement with US-based firm Generex Biotechnology Corp and its subsidiary NuGenerex Immuno-Oncology Inc for their Covid-19 vaccine in Malaysia.
Bintai Kinden’s subsidiary, Bintai Healthcare Sdn Bhd, had been granted the exclusive rights to distribute, sell and commercialise the Covid-19 vaccine. Bintai Kinden was the third most actively traded counter yesterday with some 482.8 million shares traded.
So yet another article that says Bintai is going to distribute, sell and commercialize...and no where does it say develop as in pay for the trials.
Then you add in this...
Quote:
Bamboo flooring maker Kanger International, the fifth most actively traded, yesterday with 403.6 million shares exchanging hands and the stock rising half a sen to 17.5 sen.
Kanger International diversified its business proposition and partnered China National Pharmaceutical Group Co Ltd (Sinopharm) to distribute Covid-19 vaccine to the private sector.
Bamboo Flooring maker...lol...really. Now they are getting the vaccine from our partner Sinopharm in China, yet I don't see an agreement with Sinopharm yet.
What the heck is going on here? Do we have a vaccine that a "reputable" REAL vaccine distributor would want to partner with? We have to partner with a Construction & Engineering Company, who they partners with a Real Estate developer in Australia and now the private sector of Malaysia with be with a Flooring Manufacturer.